Skip to main content

Table 3 Factors associated with antenatal HAART use

From: Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA

  N (%) OR (95% CI) AOR (95% CI) p-value
Ethnicity     
   White 309 (23) 1.0 1.0  
   Black 793 (59) 1.06 (0.82, 1.39) 0.84 (0.62, 1.13) 0.2470
   Other 248 (18) 1.15 (0.82, 1.62) 0.96 (0.66, 1.39) 0.8374
Geographic area     
   Europe 372 (28) 1.0 1.0  
   USA 978 (72) 1.79 (1.39, 2.30) 1.82 (1.40, 2.38) <0.0001
Mode of delivery     
   Vaginal delivery or non-elective caesarean 910 (67) 1.0 1.0  
   Elective caesarean 440 (33) 0.80 (0.64, 1.01) 0.99 (0.76, 1.28) 0.9366
CD4 count (entry)     
   < 400 cells per ml 586 (43) 1.0 1.0  
   ≥400 cells per ml 764 (57) 0.43 (0.35, 0.54) 0.36 (0.28, 0.46) <0.0001
CD4 count (delivery)     
   < 400 cells per ml 543 (40) 1.0 1.0  
   ≥400 cells per ml 807 (60) 0.49 (0.40, 0.62) 0.76 (0.56, 1.03) 0.0757
Viral load (entry)     
   Undetectable 570 (44) 1.00 1.0  
   Detectable 740 (56) 0.58 (0.46, 0.72) 0.48 (0.38, 0.61) <0.0001
Viral load (delivery)     
   Undetectable 626 (53) 1.0 1.0  
   Detectable 555 (47) 0.79 (0.62, 0.99) 0.97 (0.71, 1.31) 0.8197